News > Longevity 2020From science fiction to FDA submission: ectopic organoids & the commercialization of regenerative medicine
From science fiction to FDA submission: ectopic organoids & the commercialization of regenerative medicine
Michael Hufford
Co-Founder and CEO, LyGenesis
From science fiction to FDA submission: ectopic organoids & the commercialization of regenerative medicine